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1134-25 B-Type Natriuretic Peptide Predicts Lefi Ventricular 
Response to Surgery in Patients With Severe Mitral 
Regurgitation in Asymptomatic Patients With Preserved 
Left Ventricular Function 
Conlusions: NT-proBNP was closely linked to severity of aortic stenosis and therefor 
may be usefull for therapeutical decision making. 
1134-23 Is Mitral Regurgitation in Congestive Heart Failure Truly 
Functional? Evidence for Significant Biochemical 
Changes in the Valvular Extracellular Matrix 
Kathwn J. Grande-Allen. Richard W. Troughton, Allen G. Borowski, Penny L. 
Houghtaling, Nicholas R. DiPaola, Chnstine S. Moravec, Ivan Vesely. Bnan P. Griffin, 
The Cleveland Clinic Foundation, Cleveland, OH 
Background: Mitral regurgitation (MR) is a complication for many patients with congestive 
heart failure (CHF). This MR was previously thought to be functional, due to alterations in 
the cardiac geometty rather than in the valvular microstructure. In contrast, we hypothe- 
size that the geometric alterations found in CHF might be associated with biochemical 
changes in the extracellular matrix of the mitral valve. 
Methods: Mitral valves were obtained post transplant from hearts with CHF (20 dilated 
cardiomyopathy, 14 ischemlc. 3 other); all patients had undergone recent echocardio- 
graphy. Left ventricular (LV) collagen and valvular DNA, collagen, glycosaminoglycan 
(GAG), and water content were measured, normalized to tissue weight, and compared 
with autopsy controls (n=12). .Valvular and cardiac chamber dimensions and functional 
parameters were compared with biochemical parameters using a repeated measures 
generalized linear model. 
Results: The mitral leaflets in CHF had 88% more DNA, 18% more GAGS, and 6% more 
collagen than normal (p<O.O5). Mitral chordae in CHF had 83% more DNA, 42% more 
GAGS, and 8% less water (pcO.05). The elevated leaflet collagen concentration was sig- 
nificantly associated with increased anterior leaflet length and LV dimensions, and 
slightly associated with MR grade (p=O.O6). Increased leaflet DNA, an indicator of cellu- 
larity, was associated with anterior leaflet thickening (p=O.O02) and MR grade (p=O.Ol). 
Elevated leaflet GAGS were associated with left atrial diameter (p=O.O02) and alterations 
in early and late diastolic flow (~~0.05). Chordal collagen, cellularity, and water concen- 
trations were similarly associated with annular and ventricular dimensions as well as LV 
collagen concentration (pcO.04). 
Conclusion: Mitral leaflets and chordae in CHF have significant biochemical differences 
from autopsy controls. These changes in the valvular extracellular matrix occw in propor- 
tion to the alterations in cardiac dimensions that accompany CHF. Our biochemical find- 
Ing of leaflet and chordal remodeling suggests that MR in patients with CHF may not be 
purely functional, and that these mitral valves from failing hearts should not be consid- 
ered “normal.” 
1134-24 Neurohormonal Activation Is Associated With Left 
Ventricular Remodeling in Chronic Asymptomatic Mitral 
Regurgitation and Normal Lefl Ventricular Ejection 
Fraction 
Min Laurence M. Demers. Joseph Gascho, Hua Yang, John Boehmer, Benjamin C. 
Sun, Sanjay M. Mehta, Sanjay M. Mehta, Walter Pac. William Davidson, Jr., Hershey 
Medical Center, Hershey, PA 
Background: Neurohormones are elevated in patients with chronic symptomatic mitral 
regurgitation (MR) and/or left ventricular (LV) dysfunction. There is little data regarding 
neurohormonal activation in asymptomatic MR with normal resting and exercise LV func- 
tion. 
Methods: We report our initial results of a prospective study. A total of 14 normal sub- 
jects and 7 asymptomatic MR patients were enrolled. Patients had at least 3+ MR, regur- 
gitant orifice area of 0.43+0.12cm2 and resting LV ejection fraction (LVEF) of 65+5.5%. 
Plasma epinephrine, norepinephrine. renin activity and N-terminal brain natriuretic pep- 
tide (N-BNP) were measured. Resting and stress exercise echocardiography were per- 
formed. LVEF, end-diastolic diameter (LVEDD). volume, end-systolic diameter and 
volume were measured. Exercise capacity was expressed as metabolic equivalents. 
Resells: Although MR patients presented with normal resting LVEF and normal exercise 
response (increased LVEF, decreased LV end-systolic diameter with excellent exercise 
capacity-metabolic equivalents, 12*1.7), neurohormones were elevated, especially N- 
BNP (table). Significant LV remodeling was seen in the MR group with increased resting 
and post-exercise LV diameters and volumes. Conclusions: Neurohormones, especially 
N-BNP, are elevated in asymptomatic MR patients with apparently normal resting and 
exercise LV function, but dilated LV. Neurohormonal activation may indicate ongoing LV 
remodeling due to volume overload. 
W.H. Wilson Tang, Richard W. Trouahton, Deborah A. Agler, Kathy Morris, Gary S. 
Francis, Jianxin Cain. Brian P. Griffin, The Cleveland Clinic Foundation. Cleveland, OH 
Background: BNP has been validated as marker of cardiac function and prognosis in a 
variety of settings. To date, the relationship of pre- and post-op BNP to cardiac structure 
and function in asymptomatic patients with severe mitral regurgitation (MR) has not been 
well defined. Methods: We prospectively studied 22 consecutive asymptomatic patients 
(mean age 56 +13 yrs) with severe MR and LV ejection fraction (EF) =55% referred for 
mitral valve surgery. Patients undenvent pre- and post-op 2D echo evaluation, with con- 
current sampling of BNP (Biosite). LV volumes and EF were calculated by biplane Simp- 
son’s method. Cardiac dysfunction was defined as EF ~50%. Results: Mean pre-op data 
included: regurgitant orifice area = 0.88 4.4 cn?, EF = 61 *6%. LVEDV = 177 i44 ml, 
LVESV = 69 +23 ml. BNP increased acutely from 92 *73 pg/ml to 314 +200 pg/ml follow- 
ing surgery. Pre-op IogBNP correlated significantly with pre-op LA volume (r=0.49, 
p=O.O4), post-op LVESV (r= 0.50, ~~0.04) and post-op EF (r= 0.51, p=O.O3). but not with 
other echo measures. Pre-op BNP was higher in patients who developed post-op cardiac 
dysfunction (141 *85 pglml vs 57 251 pg/ml. p=O.O3). A pre-op BNP of 50 pg/ml had a 
sensitivity of 83%, specificity of 60%, and negative predictive value of 91% for prediction 
of a post-op cardiac dysfunction (r&0.8). Conclusion: Pre-op plasma BNP correlates 
significantly with post-op EF and LVESV in our study population. A pre-op plasma BNP 
below 50 pg/ml maybe useful in excluding the likelihood of post-op cardiac dysfunction. 
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1134-26 Serum B-Type Natriuretic Peptide in Patients With 
Chronic Mitral Regurgitation Is Not Elevated 
Micah J. Eimer, Deborah Ekery. Vera Rigolin, Robert 0. Bonow, William Cotts, 
Northwestern University Medical School, Chicago, IL 
Background: Chronic mitral regurgitation (MR) imposes a progressive hemodynamic 
burden upon the left ventricle (LV). Management is based on symptoms and LV size and 
function. To determine if B-Type natriuretic peptide (BNP), a hormone secreted by ven- 
tricular myocytes under strain, may be a useful marker of ventricular deterforation, we 
measured BNP levels I” patients with chronic MR. 
Methods: We studied 9 patients with moderate to severe MR and a range of symptoms 
(mean age 45 216.6) and five normal control subjects (mean age 42.2 211.1) by 2D 
echocardiography with Doppler. LV ejection fraction (EF), LV end diastolic volume 
(EDV), end systolic volume (ESV), and LV mass index (LVMI) were measured and sever- 
ity of MR was assessed semiquantitatively using color Doppler. Patients were excluded if 
they had any other valve lesion. BNP levels were measured by the Shionogi assay. 
Results: Patients and controls did not dtffer in age and had similar EF (63+12 vs 66+9%. 
p=ns). Seven of the 9 patients had severe MR and 6 had dyspnea, of whom 2 underwent 
valve surgery within 6 months. Compared to controls, the MR patients had significantly 
higher LVMI (109230 YS 72+15 s/m*. pz.02). ESV (53125 vs 2726 ml, p=.O2) and EDV 
(132H2 vs 84223 ml, pz.04). However, there was no significant difference in serum BNP 
levels (1 k_s vs 6+4 pg/ml, p=O.20) between the two groups, and BNP did not relate to 
severity of MR or to symptoms. 
Conclusion: These flndings suggest that chronic MR is not associated with elevated lev- 
